Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

JANSSEN PHARMS

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 36
  • 0 comments

FDA approve METHYLPHENIDATE HYDROCHLORIDE

Comment Full text

NOVARTIS

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 36
  • 0 comments

FDA approve METHYLPHENIDATE HYDROCHLORIDE

Comment Full text

AZURITY

  • FDA Approval
  • Oct. 16, 2023, 11:50 UTC
  • 37
  • 0 comments

FDA approve AMPHETAMINE SULFATE

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • Oct. 16, 2023, 11:50 UTC
  • 32
  • 0 comments

FDA approve PEMETREXED DISODIUM

Comment Full text

MYLAN

  • FDA Approval
  • Oct. 16, 2023, 11:50 UTC
  • 37
  • 0 comments

FDA approve SUGAMMADEX SODIUM

Comment Full text

NEOS THERAPS

  • FDA Approval
  • Oct. 16, 2023, 11:50 UTC
  • 31
  • 0 comments

FDA approve AMPHETAMINE

Comment Full text

TAKEDA PHARMS USA

  • FDA Approval
  • Oct. 16, 2023, 11:50 UTC
  • 34
  • 0 comments

FDA approve LISDEXAMFETAMINE DIMESYLATE

Comment Full text

TRIS PHARMA INC

  • FDA Approval
  • Oct. 16, 2023, 11:50 UTC
  • 33
  • 0 comments

FDA approve AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE

Comment Full text

TAKEDA PHARMS USA

  • FDA Approval
  • Oct. 16, 2023, 11:50 UTC
  • 32
  • 0 comments

FDA approve AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Comment Full text

TAKEDA PHARMS USA

  • FDA Approval
  • Oct. 16, 2023, 11:50 UTC
  • 34
  • 0 comments

FDA approve AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Comment Full text
  • Previous
  • 656
  • 657
  • 658
  • 659
  • 660
  • Next

Search

News categories

  • Technical Exchange News(13198)
  • Event(6229)
  • SEC News(332644)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(185104)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin